POLYETHYLENE GLYCOL 3350- polyethylene glycol 3350 powder, for solution 
Major Pharmaceuticals

----------

Major 44-726

Active ingredient (in each dose)

Polyethylene Glycol 3350, 17 g

Purpose

Osmotic Laxative

Use

Warnings

Allergy alert: Do not use if you are allergic to polyethylene glycol

Do not use

if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

  • nausea, vomiting or abdominal pain
  • a sudden change in bowel habits that lasts over 2 weeks
  • irritable bowel syndrome

Ask a doctor or pharmacist before use if you are

taking a prescription drug

When using this product

you may have loose, watery, more frequent stools

Stop use and ask a doctor if

  • you get diarrhea
  • you need to use a laxative for longer than 1 week
  • you have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse. These may be signs of a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

none

Questions or comments?

1-800-616-2471

Principal display panel

NDC 0904-6931-26

Compare to MiraLAX®
active ingredient*

MAJOR®

PEG3350

Polyethylene Glycol 3350
Powder for Oral Solution
Osmotic Laxative

• Relieves Occasional Constipation (Irregularity)
• Softens Stool

Dissolves in Any Beverage
Sugar Free
Unflavored

14 Once-Daily Doses
NET WT 0.5 OZ (17 g) Each

TAMPER-EVIDENT: DO NOT USE IF
FOIL IS OPEN OR BROKEN

*This product is not manufactured or distributed by Bayer HealthCare LLC,
owner of the registered trademark MiraLAX®.

Distributed by MAJOR® PHARMACEUTICALS
Indianapolis, IN 46268
www.majorpharmaceuticals.com
Rev. 03/22                             M-17                              Re-order No. 701066

Product of India                                                      50844      REV0222D72648

Major 44-726

Major 44-726

POLYETHYLENE GLYCOL 3350 
polyethylene glycol 3350 powder, for solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0904-6931
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P) (POLYETHYLENE GLYCOL 3350 - UNII:G2M7P15E5P) POLYETHYLENE GLYCOL 335017 g  in 17 g
Product Characteristics
Colorwhite (colorless upon dissolution) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0904-6931-8617 g in 1 PACKET; Type 0: Not a Combination Product06/30/2019
2NDC:0904-6931-2614 in 1 CARTON06/30/2019
217 g in 1 PACKET; Type 0: Not a Combination Product
3NDC:0904-6931-7630 in 1 CARTON06/30/2019
317 g in 1 PACKET; Type 0: Not a Combination Product
4NDC:0904-6931-81100 in 1 CARTON06/30/2019
417 g in 1 PACKET; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20392806/30/2019
Labeler - Major Pharmaceuticals (191427277)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.038154464pack(0904-6931)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.832867837pack(0904-6931)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.967626305pack(0904-6931)

Revised: 4/2024
Document Id: e8b302b6-176f-4d63-9bb6-2fb56f770250
Set id: ddc9d2b1-87d8-44fa-bac6-0a7261f33564
Version: 9
Effective Time: 20240420
 
Major Pharmaceuticals